low dose aspirin

Generic: aspirin

Labeler: ncs healthcare of ky, llc dba vangard labs
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name low dose aspirin
Generic Name aspirin
Labeler ncs healthcare of ky, llc dba vangard labs
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
NCS HealthCare of KY, LLC dba Vangard Labs

Identifiers & Regulatory

Product NDC 0615-8414
Product ID 0615-8414_d1aae137-9f68-4944-bcf4-c84bad592724
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Marketing Start 2015-06-19
Marketing End 2026-10-31

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 06158414
Hyphenated Format 0615-8414

Supplemental Identifiers

RxCUI
308416
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name low dose aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 15 TABLET, COATED in 1 BLISTER PACK (0615-8414-05)
  • 30 TABLET, COATED in 1 BLISTER PACK (0615-8414-39)
source: ndc

Packages (2)

0615-8414-05 15 TABLET, COATED in 1 BLISTER PACK (0615-8414-05) 0615-8414-39 30 TABLET, COATED in 1 BLISTER PACK (0615-8414-39)

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

LOW DOSE ASPIRIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "d1aae137-9f68-4944-bcf4-c84bad592724", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["ed9a71d6-a56e-416a-bb89-6d41307efc5a"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "15 TABLET, COATED in 1 BLISTER PACK (0615-8414-05)", "package_ndc": "0615-8414-05", "marketing_end_date": "20261031", "marketing_start_date": "20230810"}, {"sample": false, "description": "30 TABLET, COATED in 1 BLISTER PACK (0615-8414-39)", "package_ndc": "0615-8414-39", "marketing_end_date": "20261031", "marketing_start_date": "20211103"}], "brand_name": "LOW DOSE ASPIRIN", "product_id": "0615-8414_d1aae137-9f68-4944-bcf4-c84bad592724", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0615-8414", "generic_name": "ASPIRIN", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN OTC DRUG", "brand_name_base": "LOW DOSE ASPIRIN", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20261031", "marketing_start_date": "20150619"}